Let's discuss how the drugs in these two non-oncology segments are expected to have performed in the third quarter. In ...

Sun Pharmaceutical, India’s largest drugmaker by market capitalisation and revenue, is evaluating the acquisition of US-based ...

India's leading drugmaker, Sun Pharma, is contemplating a $10 billion acquisition of US-based women's health specialist, ...

Pfizer Inc. shares currently offer a dividend yield approaching 7%, ranking among the highest in the S&P 500 index. While the upcoming ex-dividend date of January 23 presents an opportunity for income ...

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, ...

China’s pharmaceutical industry, whose revenue is projected to rise by 50 per cent between 2024 and 2030, has emerged as a new growth engine for the national economy as leading players ramp up ...

According to SNS Insider, global Bioconjugation Market growth is driven by active biopharmaceutical R&D, improvements in conjugation chemistries, and the increasing use of antibody-drug ...

Rep. Julia Letlow (R-La.) reportedly violated a federal transparency law by failing to disclose her personal stock trades ...

India's largest drugmaker, Sun Pharma, is considering a major acquisition. The company is evaluating the purchase of US-based ...

Explore integrated care models, enhance digital health platforms, support caregivers, and focus on telehealth to improve FASD treatment across diverse age groups and regions Fetal Alcohol Spectrum ...

The tenosynovial giant cell tumors market is expected to grow due to rising awareness and improved disease diagnosis, the availability of advanced imaging modalities that aid earlier detection, the ...

European equities retreated from near record highs after Donald Trump announced plans to impose new tariffs on European ...